The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Cellular immunotherapy in hematological malignancies

Roeven, M.W.H.

January 2017

Contains fulltext : 178256.pdf (publisher's version ) (Open Access)Radboud Univers...

The EBMT Handbook

February 2021

This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handboo...

Does T-cell depletion have a future in allogeneic stem cell transplantation?

Witte, T.J.M. de

January 2008

Contains fulltext : 70495.pdf (publisher's version ) (Closed access

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Latour, R.P. de
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Kroger, N.
European Soc Blood Marrow Transpla

February 2020

Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Camara, R. de la
Corbacioglu, S.
Dolstra, H.
Duarte, R.
Glass, B.
Greco, R.
Lankester, A.C.
Mohty, M.
Latour, R. Peffault de
Snowden, J.A.
Yakoub-Agha, I.
Kröger, N.

January 2021

Contains fulltext : 238646.pdf (Publisher’s version ) (Open Access

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

Passweg, Jakob,
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz,
Corbacioglu, Selim
Duarte, Rafael
Dolstra, Harry
Lankester, Arjan,
Mohty, Mohamad
Montoto, Silvia
Peffault De Latour, Régis
Snowden, John,
Styczynski, Jan
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2020

International audienceHematopoietic-cell transplantation (HCT) is widely used for acquired and conge...

The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

Ljungman, P.
Mikulska, M.
Camara, R. de la
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Murray, J.
Latour, R. Peffault de
Snowden, J.A.
Yakoub-Agha, I.
Verhoeven, B.
Kröger, N.
Styczynski, J.

January 2021

Contains fulltext : 235811.pdf (Publisher’s version ) (Open Access

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg, J.R.
Baldomero, H.
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Kuball, J.
Lankester, A.
Montoto, S.
de Latour, R.P.
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Arat, M.
Mohty, M.
Kröger, N.
European Society for Blood and Marrow Transplantation (EBMT), EBMT

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
de Latour, Régis Peffault
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

January 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017 : a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

European Society for Blood and Marrow Transplantation (EBMT)

October 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT/EHA CAR-T Cell Handbook

February 2022

This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Ma...

The EBMT activity survey: 1990-2010.

Passweg, J.R.
Baldomero, H.
Gratwohl, A.
Bregni, M.
Cesaro, S.
Dreger, P.
Witte, T.J. de
Farge-Bancel, D.
Gaspar, B.
Marsh, J.
Mohty, M.
Peters, C.
Tichelli, A.
Velardi, A.
Elvira, C.R. de
Falkenburg, F.
Sureda, A.
Madrigal, A.

January 2012

Item does not contain fulltextA total of 654 centers from 48 countries were contacted for the 2010 s...

The EBMT activity survey report 2017: A focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
Peffault de Latour, Régis
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey: 1990-2010

Passweg JR
Baldomero H
Gratwohl A
Bregni M
Dreger P
Witte TD
Farge Bancel D
Gaspar B
Marsh J
Mohty M
Peters C
Tichelli A
Velardi A
de Elvira CR
Falkenburg F
Sureda A
Madrigal A
for the European Group for Blood
Marrow Transplantation
CESARO, SIMONE

January 2012

A total of 654 centers from 48 countries were contacted for the 2010 survey. In all, 634 centers rep...

The EBMT activity survey 2006 on hematopoietic stem cell transplantation : focus on the use of cord blood products

Gratwohl, A.
Baldomero, H.
Frauendorfer, K.
Rocha, V.
Apperley, J.
Niederwieser, D.
Joint, Accreditation Committee of the International Society for Cellula
European, Group for Blood
Marrow, Transplantation Ebmt

January 2008

This report describes the hematopoietic stem cell transplantation (HSCT) activity in Europe in 2006 ...

Cellular immunotherapy in hematological malignancies

Roeven, M.W.H.

January 2017

Contains fulltext : 178256.pdf (publisher's version ) (Open Access)Radboud Univers...

The EBMT Handbook

February 2021

This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handboo...

Does T-cell depletion have a future in allogeneic stem cell transplantation?

Witte, T.J.M. de

January 2008

Contains fulltext : 70495.pdf (publisher's version ) (Closed access

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Latour, R.P. de
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Kroger, N.
European Soc Blood Marrow Transpla

February 2020

Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Camara, R. de la
Corbacioglu, S.
Dolstra, H.
Duarte, R.
Glass, B.
Greco, R.
Lankester, A.C.
Mohty, M.
Latour, R. Peffault de
Snowden, J.A.
Yakoub-Agha, I.
Kröger, N.

January 2021

Contains fulltext : 238646.pdf (Publisher’s version ) (Open Access

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

Passweg, Jakob,
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz,
Corbacioglu, Selim
Duarte, Rafael
Dolstra, Harry
Lankester, Arjan,
Mohty, Mohamad
Montoto, Silvia
Peffault De Latour, Régis
Snowden, John,
Styczynski, Jan
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2020

International audienceHematopoietic-cell transplantation (HCT) is widely used for acquired and conge...

The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

Ljungman, P.
Mikulska, M.
Camara, R. de la
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Murray, J.
Latour, R. Peffault de
Snowden, J.A.
Yakoub-Agha, I.
Verhoeven, B.
Kröger, N.
Styczynski, J.

January 2021

Contains fulltext : 235811.pdf (Publisher’s version ) (Open Access

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg, J.R.
Baldomero, H.
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Kuball, J.
Lankester, A.
Montoto, S.
de Latour, R.P.
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Arat, M.
Mohty, M.
Kröger, N.
European Society for Blood and Marrow Transplantation (EBMT), EBMT

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
de Latour, Régis Peffault
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

January 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017 : a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

European Society for Blood and Marrow Transplantation (EBMT)

October 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT/EHA CAR-T Cell Handbook

February 2022

This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Ma...

The EBMT activity survey: 1990-2010.

Passweg, J.R.
Baldomero, H.
Gratwohl, A.
Bregni, M.
Cesaro, S.
Dreger, P.
Witte, T.J. de
Farge-Bancel, D.
Gaspar, B.
Marsh, J.
Mohty, M.
Peters, C.
Tichelli, A.
Velardi, A.
Elvira, C.R. de
Falkenburg, F.
Sureda, A.
Madrigal, A.

January 2012

Item does not contain fulltextA total of 654 centers from 48 countries were contacted for the 2010 s...

The EBMT activity survey report 2017: A focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
Peffault de Latour, Régis
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey: 1990-2010

Passweg JR
Baldomero H
Gratwohl A
Bregni M
Dreger P
Witte TD
Farge Bancel D
Gaspar B
Marsh J
Mohty M
Peters C
Tichelli A
Velardi A
de Elvira CR
Falkenburg F
Sureda A
Madrigal A
for the European Group for Blood
Marrow Transplantation
CESARO, SIMONE

January 2012

A total of 654 centers from 48 countries were contacted for the 2010 survey. In all, 634 centers rep...

The EBMT activity survey 2006 on hematopoietic stem cell transplantation : focus on the use of cord blood products

Gratwohl, A.
Baldomero, H.
Frauendorfer, K.
Rocha, V.
Apperley, J.
Niederwieser, D.
Joint, Accreditation Committee of the International Society for Cellula
European, Group for Blood
Marrow, Transplantation Ebmt

January 2008

This report describes the hematopoietic stem cell transplantation (HSCT) activity in Europe in 2006 ...

Cellular immunotherapy in hematological malignancies

Roeven, M.W.H.

January 2017

Contains fulltext : 178256.pdf (publisher's version ) (Open Access)Radboud Univers...

The EBMT Handbook

February 2021

This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handboo...

Does T-cell depletion have a future in allogeneic stem cell transplantation?

Witte, T.J.M. de

January 2008

Contains fulltext : 70495.pdf (publisher's version ) (Closed access

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Abstract

Extracted data

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Abstract

Extracted data

Related items

Related items